Literature DB >> 7995870

Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia.

F Leclerc1, Y Riou, A Martinot, L Storme, V Hue, V Flurin, A Deschildre, A Sadik.   

Abstract

OBJECTIVE: To report the first case of ARDS in children treated with nitric oxide (NO) inhalation.
METHODS: A 13-months infant presented with BPD and severe hypoxemia related to RSV infection and ARDS. Inhaled NO was delivered in the ventilatory circuit of a continuous flow ventilator (Babylog 8000, Dräger) in a concentration of 20-80 ppm for 7 days. NO and NO2 were continuously monitored (Polyton Draeger). Respiratory mechanics were evaluated by using the method of passive inflation by the ventilator.
RESULTS: NO inhalation improved oxygenation (tcSaO2) and reduced respiratory system resistance without affecting arterial pressure. NO2 level remained below 5 ppm, and methaemoglobin level below 1%. The child survived without neurologic sequela.
CONCLUSIONS: Two mechanisms to explain oxygenation improvement can be suggested: selective improvement in perfusion of ventilated regions and bronchodilation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995870      PMCID: PMC7095232          DOI: 10.1007/BF01711907

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  8 in total

Review 1.  Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention.

Authors:  W V La Via; M I Marks; H R Stutman
Journal:  J Pediatr       Date:  1992-10       Impact factor: 4.406

2.  Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

Authors:  C Frostell; M D Fratacci; J C Wain; R Jones; W M Zapol
Journal:  Circulation       Date:  1991-06       Impact factor: 29.690

3.  Bronchodilator action of inhaled nitric oxide in guinea pigs.

Authors:  P M Dupuy; S A Shore; J M Drazen; C Frostell; W A Hill; W M Zapol
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension.

Authors:  J Pepke-Zaba; T W Higenbottam; A T Dinh-Xuan; D Stone; J Wallwork
Journal:  Lancet       Date:  1991-11-09       Impact factor: 79.321

5.  A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection.

Authors:  D W Smith; L R Frankel; L H Mathers; A T Tang; R L Ariagno; C G Prober
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

6.  Inhaled nitric oxide for the adult respiratory distress syndrome.

Authors:  R Rossaint; K J Falke; F López; K Slama; U Pison; W M Zapol
Journal:  N Engl J Med       Date:  1993-02-11       Impact factor: 91.245

7.  Use of extracorporeal membrane oxygenation in the treatment of respiratory syncytial virus bronchiolitis: the national experience, 1983 to 1988.

Authors:  R H Steinhorn; T P Green
Journal:  J Pediatr       Date:  1990-03       Impact factor: 4.406

8.  Respiratory syncytial virus infection in children with bronchopulmonary dysplasia.

Authors:  J R Groothuis; K M Gutierrez; B A Lauer
Journal:  Pediatrics       Date:  1988-08       Impact factor: 7.124

  8 in total
  1 in total

1.  Inhaled nitric oxide therapy for severe hypoxemia in hyperinflated mechanically ventilated bronchiolitis patient.

Authors:  Alvaro DonaireGarcia; Rashmitha Dachepally; William Hanna; Samir Q Latifi; Hemant S Agarwal
Journal:  Respir Med Case Rep       Date:  2022-04-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.